| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/29/1996 | WO1996005819A1 Remedy for portal hypertension |
| 02/29/1996 | WO1996005818A1 Methods and compounds active at metabotropic glutamate receptors useful for treatment of neurological disorders and diseases |
| 02/29/1996 | WO1996005817A1 Medicament for treatment or prophylaxis of incontinence |
| 02/29/1996 | WO1996005816A1 Treatment of animals |
| 02/29/1996 | WO1996005815A1 Oestradiol-containing transdermal therapeutic system comprising hydrophylic additives |
| 02/29/1996 | WO1996005814A1 Oestradiol transdermal therapeutic system comprising hygroscopic additives |
| 02/29/1996 | WO1996005811A1 Methods for inhibiting neuronal damage |
| 02/29/1996 | WO1996005809A1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 02/29/1996 | WO1996005806A1 Compositions for treating corns and calluses |
| 02/29/1996 | WO1996005805A1 Composition for treatment of skin blisters |
| 02/29/1996 | WO1996005797A2 Agent for external application with nutrient and protective properties |
| 02/29/1996 | WO1996005740A1 Nervonic acid compositions |
| 02/29/1996 | WO1996001614A3 Rna component of telomerase |
| 02/29/1996 | WO1996001128A3 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 02/29/1996 | DE4431401A1 Lebendvakzine gegen Tumorerkrankungen Live vaccines against tumors |
| 02/29/1996 | DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects |
| 02/29/1996 | DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines |
| 02/29/1996 | DE4429786A1 Verwendung von substituierten 6-Amino-4H-pyranen Pyrans 6-amino-4H-use of substituted |
| 02/29/1996 | CA2517691A1 Endothelin antagonists |
| 02/29/1996 | CA2199949A1 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative |
| 02/29/1996 | CA2198452A1 Treatment of animals |
| 02/29/1996 | CA2198384A1 Alpa-d-pentofuranoside derivatives, process for preparing the same and their use |
| 02/29/1996 | CA2198368A1 Hyperlipemia remedy |
| 02/29/1996 | CA2198256A1 Use of n-substituted phenothiazines |
| 02/29/1996 | CA2198242A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists |
| 02/29/1996 | CA2198234A1 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | CA2198219A1 Human chemokine polypeptides |
| 02/29/1996 | CA2198129A1 Use of substituted 6-amino-4h-pyrans |
| 02/29/1996 | CA2198122A1 Methods of inhibiting viral replication |
| 02/29/1996 | CA2198120A1 Methods of inhibiting primary endometrial hyperplasia |
| 02/29/1996 | CA2198119A1 Methods of inhibiting endometrial cancer |
| 02/29/1996 | CA2198118A1 Methods for inhibiting bone prosthesis degeneration |
| 02/29/1996 | CA2198114A1 Methods of inhibiting demyelinating and dysmyelinating diseases |
| 02/29/1996 | CA2198108A1 Methods of maintaining teeth and oral bone |
| 02/29/1996 | CA2198090A1 Use of zaprinast for the manufacture of a medicament for the treatment of acute renal failure |
| 02/29/1996 | CA2198016A1 Methods of inhibiting ulcerative mucositis |
| 02/29/1996 | CA2198015A1 Methods of inhibiting neuronal damage |
| 02/29/1996 | CA2198012A1 Methods for bone healing and fracture repair |
| 02/29/1996 | CA2198011A1 Methods of reducing scarring in wound healing |
| 02/29/1996 | CA2197667A1 Compositions for treating corns and calluses |
| 02/29/1996 | CA2196979A1 7-azabicyclo¬2.2.1|-heptane and -heptene derivatives as cholinergic receptor ligands |
| 02/29/1996 | CA2196547A1 Agent for external application with nutrient and protective properties |
| 02/29/1996 | CA2195973A1 N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 02/28/1996 | EP0698612A1 Osteogenesis promoter and osteoporosis remedy |
| 02/28/1996 | EP0698611A1 Process for N-acyl-5-fluorocytidine derivatives |
| 02/28/1996 | EP0698609A1 Alpha-phosphorus substituted sulfinate derivatives as squalene synthetase inhibitors |
| 02/28/1996 | EP0698597A2 Cyclohexadiene derivatives |
| 02/28/1996 | EP0698594A1 Pharmaceutical anthraquinone derivatives |
| 02/28/1996 | EP0698392A1 Compositions containing a RAR alpha specific ligand and at least one fatty acid |
| 02/28/1996 | EP0698391A1 Use of ifenprodil and its diasterisomeren for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative disorders |
| 02/28/1996 | EP0698390A1 Use of bifemelane for the manufacture of a medicament for the treatment of hyperkinetic disorders |
| 02/28/1996 | EP0698388A1 Ophthalmic preparation for use as artificial tear |
| 02/28/1996 | EP0698347A2 Food composition containing reuterin |
| 02/28/1996 | EP0698113A1 Production of toxin binding biopolymers, use thereof |
| 02/28/1996 | EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells |
| 02/28/1996 | EP0698108A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 02/28/1996 | EP0698107A1 Gene therapy for haemophilia |
| 02/28/1996 | EP0698092A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 02/28/1996 | EP0698031A1 SIALYL LE x ANALOGUES AS INHIBITORS OF CELLULAR ADHESION |
| 02/28/1996 | EP0698027A1 Deoxythiomarinol derivatives, process and intermediates for their preparation and their use as microbicides and herbicides |
| 02/28/1996 | EP0698025A1 Ampa antagonists and a method of treatment therewith |
| 02/28/1996 | EP0698023A1 Fibrinogen receptor antagonists |
| 02/28/1996 | EP0698020A1 Pyrimidine derivatives |
| 02/28/1996 | EP0698019A1 Novel aromatic nitro compounds and their metabolites useful as anti-viral and anti-tumor agents |
| 02/28/1996 | EP0698018A1 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins, its preparation and use |
| 02/28/1996 | EP0698016A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same |
| 02/28/1996 | EP0698015A1 Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole |
| 02/28/1996 | EP0698014A1 3-phenylureido-1,5-benzodiazepine-diones useful as gastrin or cck antagonists |
| 02/28/1996 | EP0698012A1 Novel deoxygalactonojirimycin derivatives |
| 02/28/1996 | EP0698010A1 N-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 02/28/1996 | EP0698008A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | EP0697891A1 Polyoxime compounds and their preparation |
| 02/28/1996 | EP0697890A1 More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent |
| 02/28/1996 | EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |
| 02/28/1996 | EP0697874A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
| 02/28/1996 | EP0697873A1 Olefin-substituted long chain compounds |
| 02/28/1996 | EP0697871A1 Treatment process with biologically active tropane derivatives |
| 02/28/1996 | EP0697870A1 Btp receptor modulator of the gaba a?/chloride channel complex for prolonging the duration of the gaba induced membrane current |
| 02/28/1996 | EP0697869A1 Transdermal therapeutic systems for the administration of serotonin agonists |
| 02/28/1996 | EP0697868A1 Methods and compositions using optically pure (+)-zileuton |
| 02/28/1996 | EP0697867A1 Compositions in the form of solid solutions |
| 02/28/1996 | EP0697866A1 High dose formulations |
| 02/28/1996 | EP0697864A1 Treatment of septic shock |
| 02/28/1996 | EP0697863A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue |
| 02/28/1996 | EP0697862A1 Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders |
| 02/28/1996 | EP0697861A1 Oral compositions containing triclosan for the treatment of aphthous ulcers |
| 02/28/1996 | EP0697860A1 Transdermal therapeutic system containing estradiol |
| 02/28/1996 | EP0697859A1 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 02/28/1996 | EP0697858A1 Nasal drug delivery composition containing nicotine |
| 02/28/1996 | EP0697855A1 Oral compositions |
| 02/28/1996 | EP0697851A1 Composition for the treatment of impaired hair growth |
| 02/28/1996 | EP0697821A1 Cholesterol lowering drink mix compositions |
| 02/28/1996 | EP0697814A1 Pour-on formulations containinng polymeric material, glycols and glycerides |
| 02/28/1996 | EP0693051A4 Cyclopentene derivatives as endothelin receptor antagonists |
| 02/28/1996 | EP0666739A4 An intravenous solution that diminishes body protein loss. |
| 02/28/1996 | EP0661966A4 Ulcer prevention and treatment composition and method. |
| 02/28/1996 | EP0630644A4 Anti-microbial and interferon-inducing pharmaceutical compound. |
| 02/28/1996 | EP0588897B1 Non-chlorofluorocarbon aerosol formulations |
| 02/28/1996 | EP0547224B1 14-O-p-CHLOROBENZOYLACONINE AND ANALGESIC/ANTIINFLAMMATORY AGENT |